期刊名称：SCHIZOPHRENIA RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Schizophrenia Research provides rapid publication of new research that contribute to understanding the biology and treatment of schizophrenic disorders. This journal brings together biological, clinical and psychological research on this disorder, and stimulates the synthesis of findings from all those disciplines.
Types of Papers:
(1) Full-length papers: 2000-3000 words. (2) Short Communications: 1000-1500 words. (3) Special solicited research and/or reviews. (4) Comments/hypotheses. (5) Editorials. (6) Schizophrenia meeting reviews: solicited and/or submitted. (7) Book reviews. (8) Advertisements related to schizoprehnia (university positions, internationally).
Bibliographic & ordering Information
ISSN: 0920-9964
Imprint: ELSEVIER
Commenced publication 1988
|
Instructions to Authors
Submission of papers: Manuscripts from the Americas should be submitted to Prof. H.A. Nasrallah, University of Cincinnati Medical Center, Department of Psychiatry, 231 Albert Sabin Way, PO Box 670559, Cincinnati, OH 45267-0559, USA; Tel:(513)558-4615; Fax:(513)558-4616; E-mail: henry.nasrallah@uc.edu. Manuscripts from the rest of the world should be submitted to Prof. L.E. DeLisi, The Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Building 35, Orangeburg, NY 10962, USA; Tel: (212) 263-3406, Fax: (845) 398-5472; E-mail: DeLisi76@AOL.com. Manuscripts are published in English only and should be submitted in quadruplicate with accompanying disk (see "Electronic manuscripts" below).
Manuscripts submitted to the journal are only accepted on the understanding that: (1) they deal with original research and are subject to editorial revision; (2) they have not been and will not be published in whole or in part in any other journal; (3) transfer of the copyright from the author to the publisher; (4) the recommendations from the Declaration of Helsinki and the internationally accepted principles in the care and use of experimental animals have been adhered to.
Electronic manuscripts: For the initial submission of manuscripts for consideration, send a disk plus 4 printed copies. After final acceptance, your disk plus two, final and exactly matching printed copies should be submitted together. Double density (DD) or high density (HD) diskettes (3?inch) are acceptable. It is important that the file saved is in the native format of the wordprocessor program used. Label the disk with the name of the computer and wordprocessing package used, your name, the manuscript number and the name of the file on the disk. Further information may be obtained from the Publisher.
Manuscripts should be typewritten with double spacing throughout with at least 3cm margin. Manuscripts should be concisely written in a readily understandable style. Standard nomenclature should be used throughout; unfamiliar or new terms and arbitrary abbreviations should be defined when first used. Unnecessary abbreviations and "laboratory slang" are to be avoided. Each manuscript must have a separate title page which includes only the title, authors' full names, academic or professional affiliations and complete addresses, as well as the name, address, E-mail, telephone and fax numbers of the author to whom proofs and correspondence should be addressed. The title should be short, clear and concise and should indicate the major point of the paper. The page following the title page should include a summary of about 200 words for full-length papers and 50-70 words for short communications, and up to six key words. The remaining text should be organized as follows:
Introduction. This should give the reasons for undertaking the study and a summary of the experimental plan. Exhaustive reviews of literature should be avoided.
Methods. These should be described in sufficient detail so that the work can be duplicated, or by reference to previous descriptions if they are readily available. Commonly used methods require only a citation of the original source unless they have been substantially modified. Statistical tests used for evaluation of data should be briefly explained. In case of experimental studies, animals used should be described, including information of breed, breeder, sex, age, weight and the maintenance conditions. Special chemicals and drugs with their sources should be grouped under a separate sub-heading ("material" or "drugs"). For drugs, generic names should be used; trade names may be given in brackets where the drug is first mentioned. In case of new drugs, a detailed chemical description (formula) should be given. The form of the drug used should be indicated.
Results. In this section the findings should be described clearly, concisely, andin logical order without extended discussions of their significance. Only in case of short communications, the results and discussion sections may be combined. Results should usually be presented in graphic or tabular form, rather than discursively. There should be no duplication in text, tables and figures. Experimental conclusions should normally be based on adequate numbers of observations with statistical analysis of variance and the significance of differences. The number of individual values represented by a mean should be indicated.
Discussion. This section should present conclusions to be drawn from the results accompanied by an assessment of their significance in relation to previous work. Speculative discussion is not discouraged, but the speculation should be based on the data presented and identified as such. In general, the discussion should be as concise as possible.
Acknowledgements. These may be included at the end of the discussion section under a separate heading.
Literature references. References in the text to literature cited should be given by the name of the author(s), followed by the year of publication in parentheses, e.g.: Downie and Larsson (1984) or (Hicks et al., 1984, 1985; Stoof and Kebabian, 1984; Seeman et al., 1985). For three or more authors the name of the first author followed by et al. should be used. All references cited in the text should be listed at the end of the paper on a separate page (double-spaced) arranged in alphabetical order of first author. All items in the reference list should be cited in the text and, conversely, all references cited in the text must be presented in the list. The form of literature references to books should be: author, initials, year, title of book, publisher and city, and page number referred to (see example A). Literature references to journal articles must be complete, including initials of the authors cited, year, title of paper referred to, abbreviated title, volume, and first and last page numbers of the article, in a periodical (see example B). The abbreviations of journal titles should conform to the List of Serial Title Word Abbreviations (available from International Serials Data System, 20 rue Bachaumont, 75002 Paris, France. ISBN 2-904939-02-8). References to authors contributing to multi-author books, books in a series or to proceedings printed in book form should be similar to those for books (see example C).
Examples:
A. Haase, H.-J. and Janssen, P.A.J. (Eds.), 1985. The Action of Neuroleptic Drugs, 2nd rev. edn. Elsevier, Amsterdam, p. 364.
B. Arora, R.C., Locascio, J.J. and Meltzer, H.Y., 1986. 3H- Imipramine binding in blood platelets of schizophrenic patients. Psychiatry Res. 19, 215-224.
C. DeLisi, L.E., 1986. Neuroimmunology: clinical studies of schizophrenia and other psychiatric disorders. In: Nasrallah, H.A. (Series Ed.), Handbook of Schizophrenia, Vol. 1: H.A. Nasrallah and D.K. Weinberger (Eds.), The Neurology of Schizophrenia. Elsevier, Amsterdam, pp. 377-396.
This journal should be cited in lists of references as Schizophr. Res.
Presentation of data in tables and figures. In general, tables and figures should be so constructed that they, together with their captions and legends, will be intelligible with minimal reference to the text.
Each table should be on a separate page. Tables should be numbered consecutively with Arabic numerals (Tables 1, 2, etc.). The title of the table should appear above and detailed description of its contents (if necessary) below the title of the table. Footnotes and statistical significance should be given below the body of the table.
Figures should be submitted in triplicate as unmounted glossy photographs and reach the editors in a form and condition suitable for reproduction either across a single column (=7.7cm) or a whole page (=16.4cm). Lettering should be clear and of adequate size to be legible after reduction. Photographs, including roentgenograms, electroencephalograms, and electron micrographs should be supplied as clear black-and-white prints on glossy paper, rather than copies which reproduce detail badly, usually larger than the final size of reproduction, but not more than 20 x 25 cm. The degree of reduction will be determined by the publisher, but in general it should be assumed that the same degree of reduction will be applied to all figures in the same paper. Reproduction in color will have to be approved by the editors. The extra costs of color reproduction will be charged to the author(s). The authors' names and the number of the figure should be placed on the back of each photograph. Legends for figures should be numbered consecutively in arabic numerals and should appear on a separate page at the end of the manuscript. All symbols and abbreviations used in the figure must be explained. Data in tables and figures should be presented as clearly defined meanvalues with some measure of their dispersion (standard deviation, standard error, range) and an appropriate indication of the statistical significance of differences from control values. The number of individual values represented by a mean should be indicated.
Proofs. Authors should keep a copy of their manuscripts as proofs will be sent to them without manuscript. Only printer's errors may be corrected; no change in, or addition to, the edited manuscript will be allowed at this stage.
Reprints. A total of 50 reprints of each paper will be provided free of charge to the author(s). Additional copies can be ordered at prices shown on a separate price list which will be sent to the authors with the reprint order form.
Proofs and reprint order form should be returned to Elsevier Science Publishers B.V., P.O. Box 1527, 1000 BM Amsterdam, The Netherlands. In case of courier service, please use the following address: Elsevier Science Publishers B.V., Molenwerf 1, 1014 AG Amsterdam, The Netherlands.
Editorial Board
Co-Editors:
H.A. Nasrallah, Department of Psychiatry, University of Cincinnati Medical Center, Dept. of Psychiatry, 231 Albert Sabin Way, PO Box 670559, Cincinnati, OH 45267-0559, USA
L.E. DeLisi, The Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Building 35, Orangeburg, NY 10962, USA
Managing Editor:
A.T. Nasrallah, USA
Editorial Board:
J. Addington, Canada
M. Albus, Germany
N.C. Andreasen, USA
R.J. Baldessarini, USA
T.R.E. Barnes, UK
F.M. Benes, USA
R.A. Bornstein, USA
D.L. Braff, USA
E. Cantor-Graae, Sweden
A. Carlsson, Sweden
W.T. Carpenter, USA
E.Y. Chen, Hong Kong
D.L. Copolov, Australia
T.J. Crow, UK
M. Davidson, Israel
K.L. Davis, USA
J.F.W. Deakin, UK
R. Elmsley, South Africa
L. Fananás, Spain
A.E. Farmer, UK
R. Freedman, USA
D.L. Garver, USA
W.F. Gattaz, Brazil
A.I. Green, USA
M.F. Green, USA
R.E. Gur, USA
P.D. Harvey, USA
F.A. Henn, Germany
S.R. Hirsch, UK
A. Jablensky, Australia
J.M. Kane, USA
S. Kapur, Canada
R. Keefe, USA
J.L. Kennedy, Canada
M.S. Keshavan, USA
L. Kopala, Canada
D.A. Lewis, USA
J.A. Lieberman, USA
W. Maier, Germany
S.R. Marder, USA
P. McGorry, Australia
J.J. McGrath, Australia
H.Y. Meltzer, USA
R.M. Murray, UK
C.B. Nemeroff, USA
M.J. Owen, UK
J. Peuskens, Belgium
S.C. Schulz, USA
G. Sedvall, Sweden
M.V. Seeman, Canada
T. Sharma, UK
M.E. Shenton, USA
N. Takei, Japan
C.A. Tamminga, USA
R. Tandon, USA
E.F. Torrey, USA
M.T. Tsuang, USA
J. Van Os, The Netherlands
H. Verdoux, France
A. Vita, Italy
D.R. Weinberger, USA
Manuscripts from the Americas should be submitted to Prof. H.A. Nasrallah, University of Cincinnati Medical Center, Department of Psychiatry, 231 Albert Sabin Way, PO Box 670559, Cincinnati, OH 45267-0559, USA; Tel:(513)558-4615; Fax:(513)558-4616; E-mail: henry.nasrallah@uc.edu. Manuscripts from the rest of the world should be submitted to Prof. L.E. DeLisi, The Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Building 35, Orangeburg, NY 10962, USA; Tel: (212) 263-3406, Fax: (845) 398-5472; E-mail: DeLisi76@AOL.com. Manuscripts are published in English only and should be submitted in quadruplicate with accompanying disk (see "Electronic manuscripts" below).
|
